stability studies – Page 5

Ongoing Stability Testing Frequency Errors and How to Prevent Them

Addressing Frequency Errors in Ongoing Stability Testing Programs In the pharmaceutical industry, ongoing stability program gaps can lead to significant regulatory compliance challenges and potential risks to product quality. These…

Common Failures in Selecting Batches for Ongoing Stability Programs

Tackling Common Failures in Batch Selection for Stability Programs The ongoing stability program (OSP) is a critical component of pharmaceutical quality assurance, ensuring that drug products remain effective and safe…

How to Design an Ongoing Stability Program for Commercial Products

Creating an Effective Ongoing Stability Program to Address Common Gaps Managing ongoing stability program gaps in pharmaceutical manufacturing is critical for ensuring product quality and regulatory compliance. A robust stability…

Ongoing Stability Program Gaps That Lead to Regulatory Observations

Identifying and Addressing Gaps in Ongoing Stability Programs to Prevent Regulatory Issues Ongoing stability program gaps can pose significant regulatory risks in the pharmaceutical industry. When stability data is not…

Label Claim Case Study: Changing Storage Statement After Stability OOT

Understanding Storage Statement Changes After Stability Out-of-Trend Results In the dynamic landscape of pharmaceutical manufacturing, a situation often arises where stability data indicates out-of-trend (OOT) results, compelling the need to…

Problem-Solution Guide to Stability Study Management

A Practical Guide to Managing Challenges in Stability Studies In the realm of pharmaceutical development and manufacturing, stability studies serve a critical role in ensuring the quality and efficacy of…

How to Write CAPA When Label Claim Evidence Is Inadequate

Creating Effective CAPA Documentation for Inadequate Evidence of Label Claims In the pharmaceutical industry, having robust documentation and processes in place is critical to ensuring product quality and regulatory compliance.…

Stability Studies for Emerging Markets and Zone IVb Conditions

Addressing Challenges in Stability Studies for Zone IVb Conditions In today’s global pharmaceutical landscape, stability studies are crucial in ensuring product quality and efficacy, particularly when subjected to varying climatic…

Label Claim Justification for Medical Device Combination Products

Justifying Label Claims for Medical Device Combination Products The pharmaceutical landscape is increasingly integrating medical devices with combination products, which adds complexity to label claim justification. Professionals in manufacturing, quality…

How to Improve Stability Study Efficiency Without Compliance Risk

Enhancing the Efficiency of Stability Studies While Ensuring Compliance In today’s competitive pharmaceutical environment, ensuring the efficiency of stability studies without compromising compliance is paramount. Failure to conduct effective stability…

How to Prepare a Stability Summary for Label Claim Approval

Essential Steps for Creating a Stability Summary for Label Claim Approval In the pharmaceutical industry, the preparation of a comprehensive stability summary is critical for securing approval of label claims.…

Stability Study Risk Assessment for High-Risk Products

Assessing Risks in Stability Studies for High-Risk Pharmaceutical Products In the pharmaceutical industry, the integrity and efficacy of products are paramount, particularly for high-risk items that require comprehensive evaluation throughout…